|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Credit Suisse on 2021-02-17. The analyst firm set a price target for 26.00 expecting IMVT to rise to within 12 months (a possible 57.58% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Immunovant (NASDAQ: IMVT) is $16.5 last updated Today at 2:51:00 PM.
There are no upcoming dividends for Immunovant.
There is no upcoming split for Immunovant.